LEVONORGESTREL AND ETHINYL ESTRADIOL Drug Patent Profile
Which patents cover Levonorgestrel And Ethinyl Estradiol, and what generic alternatives are available?
Levonorgestrel And Ethinyl Estradiol is a drug marketed by Glenmark Pharms Ltd, Lupin Ltd, Naari Pte, Watson Labs, Xiromed, Barr, Amneal Pharms, Dr Reddys Labs Sa, Hetero Labs, and Lupin. and is included in twenty-nine NDAs.
The generic ingredient in LEVONORGESTREL AND ETHINYL ESTRADIOL is ethinyl estradiol; levonorgestrel. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LEVONORGESTREL AND ETHINYL ESTRADIOL?
- What are the global sales for LEVONORGESTREL AND ETHINYL ESTRADIOL?
- What is Average Wholesale Price for LEVONORGESTREL AND ETHINYL ESTRADIOL?
Summary for LEVONORGESTREL AND ETHINYL ESTRADIOL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 74 |
| What excipients (inactive ingredients) are in LEVONORGESTREL AND ETHINYL ESTRADIOL? | LEVONORGESTREL AND ETHINYL ESTRADIOL excipients list |
| DailyMed Link: | LEVONORGESTREL AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for LEVONORGESTREL AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| HIV Prevention Trials Network | PHASE2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | PHASE2 |
| Atea Pharmaceuticals, Inc. | PHASE1 |
See all LEVONORGESTREL AND ETHINYL ESTRADIOL clinical trials
Pharmacology for LEVONORGESTREL AND ETHINYL ESTRADIOL
| Drug Class | Estrogen Progestin Progestin-containing Intrauterine System |
| Mechanism of Action | Estrogen Receptor Agonists |
| Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for LEVONORGESTREL AND ETHINYL ESTRADIOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 205131-001 | Dec 14, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Xiromed | LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 200492-001 | May 27, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | LEVONORGESTREL AND ETHINYL ESTRADIOL | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 202791-001 | Apr 9, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
